Development and validation of a machine-learning ALS survival model lacking vital capacity (VC-Free) for use in clinical trials during the COVID-19 pandemic
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Development and validation of a machine-learning ALS survival model lacking vital capacity (VC-Free) for use in clinical trials during the COVID-19 pandemic
Authors
Keywords
-
Journal
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
Volume 22, Issue sup1, Pages 22-32
Publisher
Informa UK Limited
Online
2021-08-05
DOI
10.1080/21678421.2021.1924207
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Addressing heterogeneity in amyotrophic lateral sclerosis CLINICAL TRIALS
- (2020) Namita A. Goyal et al. MUSCLE & NERVE
- Optimizing Telemedicine to Facilitate ALS Clinical Trials
- (2020) Raghav Govindarajan et al. MUSCLE & NERVE
- Amyotrophic Lateral Sclerosis Care and Research in the USA During the COVID ‐19 Pandemic: Challenges and Opportunities
- (2020) Jinsy A. Andrews et al. MUSCLE & NERVE
- Telemedicine and technological devices for amyotrophic lateral sclerosis in the era of COVID-19
- (2020) Fabiola De Marchi et al. NEUROLOGICAL SCIENCES
- Telemedicine is a useful tool to deliver care to patients with Amyotrophic Lateral Sclerosis during COVID-19 pandemic: results from Southern Italy
- (2020) Rosa Capozzo et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Amyotrophic lateral sclerosis: update on clinical management
- (2020) Simone P. Norris et al. CURRENT OPINION IN NEUROLOGY
- Telemedicine for patients with amyotrophic lateral sclerosis during COVID-19 pandemic: an Italian ALS referral center experience
- (2020) Rosario Vasta et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- PROBAST: A Tool to Assess Risk of Bias and Applicability of Prediction Model Studies: Explanation and Elaboration
- (2019) Karel G.M. Moons et al. ANNALS OF INTERNAL MEDICINE
- Refining eligibility criteria for amyotrophic lateral sclerosis clinical trials
- (2019) Ruben P.A. van Eijk et al. NEUROLOGY
- A phase III trial of tirasemtiv as a potential treatment for amyotrophic lateral sclerosis
- (2019) Jeremy M. Shefner et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Clinical trials in amyotrophic lateral sclerosis
- (2019) Christopher J. McDermott CURRENT OPINION IN NEUROLOGY
- Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model
- (2018) Henk-Jan Westeneng et al. LANCET NEUROLOGY
- Improved stratification of ALS clinical trials using predicted survival
- (2018) James D. Berry et al. Annals of Clinical and Translational Neurology
- Assessing calibration of prognostic risk scores
- (2016) Cynthia S Crowson et al. STATISTICAL METHODS IN MEDICAL RESEARCH
- Being PRO-ACTive: What can a Clinical Trial Database Reveal About ALS?
- (2015) Neta Zach et al. Neurotherapeutics
- Towards better clinical prediction models: seven steps for development and an ABCD for validation
- (2014) E. W. Steyerberg et al. EUROPEAN HEART JOURNAL
- To Explain or to Predict?
- (2011) Galit Shmueli STATISTICAL SCIENCE
- ALS motor phenotype heterogeneity, focality, and spread: Deconstructing motor neuron degeneration
- (2009) J. M. Ravits et al. NEUROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation